Comparative Efficacy Evaluation of Lipids When Treated With Niaspan & Statin or Other Lipid-Modifying Therapies-COMPELL
Status:
Completed
Trial end date:
2005-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effectiveness of first-line treatment using
Niaspan (an extended release version of niacin) and statins versus other drugs that lower
lipid levels, in subjects with elevated fat levels in their blood (dyslipidemia). Statins are
a class of medication that is often prescribed to patients who need to lower their
cholesterol levels.